Makers of benicar agree to settle for $300 million
$300 Million Settlement Reached in Benicar Lawsuit
August 2, 2017
The makers of the blood pressure medication Benicar have agreed to pay $300 million to settle claims that the drug caused gastrointestinal injuries.
In the settlement, which was reached in a federal court in New Jersey, drugmakers Daiichi Sankyo and Forest Laboratories will pay the $300 million to end the many cases that comprise the Multi-District Litigation (MDL) case.
Central to the suits were claims that Benicar was defective in that it could cause chronic diarrhea, dehydration, malnutrition, nausea, and weight loss. At the prompting of the U.S. Food and Drug Administration, Daiichi and Forest had altered Benicar’s label in 2013 to indicate that the drug had been linked to a condition called sprue-like enteropathy, which entails chronic and severe diarrhea.
The FDA had identified 23 cases of severe diarrhea that were linked to Benicar.
If you’ve taken Benicar and have experienced gastrointestinal distress or disease, you may still be entitled to be part of a lawsuit. Contact the expert attorneys at TheLawFirm.com to find out how.
Benicar Related Articles
Benicar Side Effects & Warnings
TheLawFirm.com’s award winning lawyers have been featured in over 50 radio and television interviews including:
Real lawyers, real results!
no recovery, no fee!